You are here

InnoCan Pharma Corporation

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
INNO
CSE Index: 
Currency: 

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

You are here

InnoCan Pharma Corporation (INNO)

SEDAR Information

Company Info

Address
1015, 926 - 5 Avenue SW
Calgary, AB T2P 0N7
Canada
Phone
403-777-1519
Email
irisb@innocanpharma.com
Website
http://innocanpharma.com
Listing date
Tuesday, September 24, 2019
Transfer Agent
Odyssey Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
175,342,521
Reserved for Issuance: 
22,666,583

Bulletins

24/09/2019

2019-0927 – New Listing - InnoCan Pharma Corporation (INNO)

le 24 septembre/September 2019

The common shares of InnoCan Pharma Corporation have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-07-03-Tech-Tuesday_Transportation_Newsletter_Website

Tech Tuesdays

Tuesday, July 14, 2020 -
4:15pm to 5:00pm
07-15_Virtual_Industry_Updates_Tech_Strikes_Back_Website

Virtual Industry Updates: Tech Strikes Back

Wednesday, July 15, 2020 -
3:00pm to 4:15pm
08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm